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Abstract - Trans urethral resection of prostate (TURP) is a standard procedure in benign prostate hyperplasia (BPH) management, 
however it may face with complication such as hemorrhage that may increase morbidity and mortality rate. This study is designed to find 
the efficacy combination dutasteride and green tea in reducing hemorrhage on TURP patients  and to evaluate the anti-angiogenesis 
effect. Double Blind Randomized Controlled Trial Post Test Only Design with 80 subjects, randomized into 4 groups : three treatment 
groups (T1 with 0.5mg of dutasteride, T2 with 725mg of green tea extract and T3 with combination of 0.5mg dutasteride and 725mg of 
green tea extract and one control group (C) at least 14 days before TURP procedure. We compared the ΔHb (haemoglobin) to evaluate 
the hemorrhage status and define the VEGF expression and MVD count to evaluate the angiogenesis changes between four groups. The 
study revealed ∆Hb (pg/mL) for T1(-0.20+0.067) T2(-0.18+0.081) T3(-0.14+0.092) and C(-0.40+0.246). VEGF expression were 
T1(12.90+15.509), T2(11.60+9.121), T3(3.60+1.667) and C(20.20+17.386). MVD count median were T1(33), T2(31.5), T3(24) and C(42). 
The result from between subject effect tests showed statistically significantly reduce ΔHb, VEGF expression and MVD count. Multivariate 
analysis showed that the combination of dutasteride and green tea significantly reduce the hemorrhage during TURP (ΔHb) by 
decreasing the MVD. Administration of oral combination of  0.5mg dutasteride and 725mg of green tea extract, for at least 14 days prior 
to undergoing TURP significantly reduce the hemorrhage during TURP by decreasing the MVD. 
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I. INTRODUCTION 
Benign prostate hyperplasia (BPH) is a disease in 
elderly. BPH is the second most frequent disease found in 
urological clinics in Indonesia, just behind urinary tract 
stone (Fadlol and Mochtar, 2005). Trans urethral 
resection of prostate (TURP) is a gold standard treatment 
to reduce the lower urinary tract symptoms and urinary 
retention in BPH patient that untreatable with medication. 
The most common complication, both during and post 
operation is hemorrhage that significantly affect the 
morbidity and mortality (Shanmugasundaram et al., 2007; 
Kim et al., 2015; Boccon et al., 2005; Hahn et al., 2007).  
The pathologic process on BPH involves the 
angiogenesis, increasing number and surface area of 
prostate vessels, that resulted in hemorrhage during 
TURP procedure. A number of studies has tried to find the 
factor to reduce angiogenesis (anti angiogenic therapy), 
one of them used 5-alpha reductase inhibitor, inhibits the 
conversion of testosterone into dehydotestosterone 
(DHT) that trigger the prostate enlargement (Chapple, 
2004). 5-alpha reductase inhibitor also plays important 
role in androgen dependent angiogenic growth factor 
reduction, such as VEGF, sub urothelial microvessel 
density and blood vessels reduction, resulting prostate 
size reduction and apoptosis induction (Chapple, 2004; 
Clark et al., 2004). This type of drug consists of finasteride 
and dutasteride. Dutasteride selectively inhibits both 5-
alpha reductase isoenzym (type 1 and 2). Both of 
finasteride and dutasteride  are beneficial in reducing 
hemorrhage during TURP procedure. They have a distinct 
pharmacokinetic system, dutasteride has a longer half life 
and some studies has mentioned that dutasteride is more 
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effective in reducing DHT, more effective in reducing 
angiogenesis process and less adverse effect (Nickel, 
2004). The possible side effects during long term 5-alpha 
reductase treatment are impotency, changes in libido, 
ejaculation disorder, and gynecomastia (Trost, 2013). 
Green tea is a phytopharmaceutical with considerable 
anti angiogenesis agent. Epigallocatechin gallate (EGCG), 
one of active substances in green tea, has been proven to 
inhibit the angiogenesis process (Fassina et al., 2004). It 
has been reported to inhibit the urokinase and tyrosin 
kinase activation, therefore inhibit the activities of VEGF, 
IGF, EGF, and FGF (Adhami et al., 2009). After all, green 
tea inhibits the tumor growth by supressing the vascular 
growth. Administered together, it sound logically accepted 
that dutasteride and green tea has a synergism effect in 
angiogenesis inhibition. 
It is suspected the combination off both agents, will 
reduce the hemorrhage as the risk of TURP procedure. 
This study was designed to evaluate the hemorrhage 
difference and VEGF activities that affect the reduction of 
MVD and inhibits the capillary endothelial cells growth. In 
the end, the angiogenesis will be reduced and prostatic 
vascularitation will be suppressed, finally, there will be 
less hemorragic blood volume during TURP procedure. 
 
II. MATERIALS AND METHOD 
This study was designed as an experimental double 
blind randomized controlled trial post test only. We tried 
to compare the angiogenesis changes by evaluating the 
VEGF expression, MVD count, haemoglobin (Hb) value, 
and blood transfusion rate in four groups of subjects: 
dutasteride only, green tea extract only, placebo, and 
combination of dutasteride and green tea groups, at least 
14 days before TURP. 
The subjects of the study were patients with TURP 
procedure to treat their BPH. The groups were pre-
treated with 0.5 mg dutasteride capsule, 725 mg green tea 
extract capsule, combination of two former agents, and 
placebo in group T1, T2, T3, and C respectively. 
The pre and post (2 hours after the procedure at the 
latest) procedural Hb values were obtained from all 
subjects along with another routine blood laboratory 
check as a prerequisite of the procedure. We determined 
the difference of pre and post procedure Hb value. The 
blood transfusion needs determined based on the post 
procedural Hb values, with less than 10 mg/dL as base 
value. 
Every subjects underwent prostatic TRUS procedure 
to determine the exact volume of the prostate. All TURP 
procedures were commenced under spinal anesthesia. All 
TURP procedures were lead by an urologist surgeon using 
24-F resectoscope (Karl Storz, Germany). We used 
aquadest as irigation fluid, and the volume in every 
procedure was recorded, as well as the duration of the 
procedure. The tissue subjects were obtained to evaluate 
the VEGF and MVD status by pathologist. VEGF expression 
were evaluated with immunohistochemistry staining 
under 100x microscopic magnification, Olympus BX-41. 
The MVD count were measured with CD34 surface marker 
under 100x microscopic magnification as well.  
The results data were processed and presented in 
graphics. We used one way ANOVA test and Kruskall 
Wallis test to determine the variation of the groups when 
apropriate. We proceed with Mann Whitney U test and 
Post Hoc test to evaluate the statistical significance 
(p<0.05). To observe the correlation of each variables 
Pearson’s product moment bivariate correlation test were 
performed. All statistical analysis were processed by 
computer using the SPSS. This study received its ethical 
clearance from Health Study Ethical Commision of 
Medical Faculty Diponegoro University and Kariadi 
General Hospital, number 292/EC/FK/RSDK/2012. This 
study was conducted from July 2012 until May 2013. 
 
Table 1. Demographic and clinical characteristic of subjects included in curent study 
Confounding Factors 
Mean ± SD 
p C T1 T2 T3 
Age (year) 70.3 ± 6.626 69.9 ± 8.950 68.1 ± 7.732 69.5 ± 9.944 0.855 
Prostatic weight (gram) 39.4 ± 12.923 45.3 ± 17.946 46.0 ± 17.096 43.7 ± 14.737 0.555 
The duration of the 
treatment (day) 16.20 ± 1.704 15.95 ± 1.572 16.00 ± 1.414 15.85 ± 1.461 0.908 
The duration of 
catheter placement 
(day) 17.53 ± 2.129 18.00 ± 2.152 17.60 ± 2.349 17.00 ± 1.622 0.532 
The duration of the 
TURP (minute) 34.40 ± 3.979 34.65 ± 3.514 35.45 ± 2.762 34.90 ± 3.007 0.782 
The irrigant fluid 
needed during the 
TURP (litre) 6.95 ± 0.780 7.04 ± 0.719 7.11 ± 0.596 6.97 ± 0.603 0.868 
The time needed after 
the TURP procedure to 
obtain the blood 
subjects for Hb 
examination (minute) 
85.00 ± 13.514 
 
 
84.00 
±15.526 
 
 
84.50 
±14.681 
 
 
83.50 ± 9.473 
 
 
0.807 
 
 
T1 = group of 0.5 mg dutasteride / day, T2 = group of 725mg green tea extract/ day,  T3 = group of the 
combination of 0.5 mg dutasteride and 725 mg green tea extract / day. C = the control group (placebo).  
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III. RESULTS AND DISCUSSION 
We recruited 90 subjects with urinary retention, 
planned to undergo TURP pocedure, and all of them 
fulfilled the inclusion and exclusion criteria. The subject 
receive the treatment at least 14 days before TURP 
procedure. 
Seven subjects were out of the analysis: 2 of them 
were unable to comply the treatment (both from T1), 3 
subjects were aborted due to comorbid of New York Heart 
Association (NYHA) level III congestive heart failure 
(CHF)  (2 from T2 and 1 from T3), 3 subjects were lost 
during follow-up period (2 from C group). We managed to 
have a data set from 83 subjects to be analyzed. 
The average age of the subjects is 69.44 + 8.287 years 
old with 48 and 87 as the youngest and the oldest 
respectively. The average prostatic weight is 43.62 + 15.7 
grams, with 18.6 and 85 grams as the minimum and 
maximum weight. The duration of the treatment are 16 + 
1.5 14 and 19 days for the average the shortest and longes 
duration respectively. The duration of catheter placement 
are 17.53 + 2.129 14 and 23 days for the average the 
shortest and longes duration respectively. The duration of 
the TURP are 34.85 + 3.307  27 and 44 minutes in average 
the shortest and the longest duration respectively. The 
irrigant fluid needed during the TURP were 7.016 + 0.669 
litres, 5.8 litres and 8.8 litres in average minimum and 
maximum volume respectively. The time needed after the 
TURP procedure to obtain the blood subjects for Hb 
examination were 85 + 13.36, 50 and 120 minutes for the 
average minimum and maximum values respectively. The 
statistical test for all variables in all groups showed p 
>0.05 therefore no statistically significant difference in 
age, prostatic volume, treatment duration, catheter 
placement duration, procedure time, irrigant volume, and 
time needed until blood collection. Therefore, the 
confounding factors were able to be controlled. 
 
 
Figure 1. This diagram shows the difference Hb levels pre 
and post-TURP in four groups: 
T1 = group of 0.5 mg dutasteride / day, T2 = group of 
725mg green tea extract/ day,  T3 = group of the 
combination of 0.5 mg dutasteride and 725 mg green tea 
extract / day. C = the control group (placebo).  
T3 most effectively suppress the bleeding compared to 
other groups. 
The Mann-Whitney test showed a significant 
difference of ΔHb between T2 and T3 groups and also T1 
and T3 groups. There is no significant difference in ΔHb 
between T1 and T2. Therefore. ΔHb in T3 is significantly 
lower compared with T1 and T2. 
 
 
Figure 2. This diagram shows the difference VEGF expression 
after treatment in four groups : 
T1 = group of 0.5 mg dutasteride / day, T2 = group of 725mg 
green tea extract/ day,  T3 = group of the combination of 0.5 
mg dutasteride and 725 mg green tea extract / day. C = the 
control group (placebo).  
T3 lowest its VEGF expression  compared to other groups. 
 
 
Figure 3. This diagram shows the difference MVD count after 
treatment in four groups : 
T1 = group of 0.5 mg dutasteride / day, T2 = group of 725mg 
green tea extract/ day,  T3 = group of the combination of 0.5 
mg dutasteride and 725 mg green tea extract / day. C = the 
control group (placebo).  
T3 lowest its MVD count  compared to other groups. 
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The VEGF expression in treatment groups (T1. T2. T3) 
was significantly different compared to control group. 
There is significant difference in VEGF expression 
reduction between T2 and T3 groups and T1 and T3 
groups. There was no significant difference between T1 
and T2. Therefore. the VEGF expression in T3 were 
significantly lower compared to T1 and T2. 
The post hoc test analysis showed significant 
reductions in group T1. T2. T3 compared with K. There 
were significant MVD count between T2 and T3. and also 
between T1 and T3. but not in T1 and T2. Therefore MVD 
count in T3 was much more significant compared with T1 
and T2. 
 
          
 
 
 
 
 
 
Multivariate analysis showed that the combination of 
dutasteride and green tea significantly reduce the number 
of bleeding (Δ Hb) by decreasing the MVD. The possible 
factors that affect the hemorrhage volume during TURP 
procedure in all study subjects are : age, prostate volume, 
medical treatment duration, Catheter placement duration, 
operation time, irrigant fluid volume, and time until blood 
sample drawn after TURP procedure. All off them are well 
controlled and unable to affect the validity of study results 
(Walsh and Retik, 1998). 
The study showed that the lowest amount of bleeding 
complication (∆Hb) is in the T group. The study also 
showed that combination of dutasteride and green tea 
reduced the hemorrhage count due to MVD count 
supression. 
Angiogenesis is an adaptation process by creating a 
new blood vessel to respond the environmental changes 
that endanger the tissue. Angiogenesis itself can be 
pathological or physiological. The physiologic type occurs 
during growth of the tissue healing and menstrual cycle in 
women. The pathological type occurs during malignancy 
or infectious disease, vascular formation, and other 
hypoxic-induced condition (Carmeliet and Jane, 2000). 
The angiogenesis starts with trigerring factors, and it 
most case it will be hypoxic status. In tumor, the distant 
between the vessel and the cell affects the oxygen level 
diffusing into the cells. This condition, known as hypoxia, 
it will trigger the hypoxic-indicible factor 1α (HIF-1α) and 
increase the transcription process of angiogenic factor 
genes. HIF-1α also plays role on wether the cell move into 
apoptotic mode or not. The mechanical stress 
(intratumoral high pressure), inflammation/immune 
response, and genetic mutation on oncogene or tumor 
supressor gene, also play their part in angiogenesis 
(Hicklin and Ellis, 2005). 
Hipervascularisation in prostate ussualy accounts for 
hemorrhage in BPH patient. The angiogenesis supression 
can be tried by manipulating the hormone that inhibits 
the testosterone. The blood flow into the prostate will be 
very affected by the testosterone (Lee, 1996). 
Testosterone triggers the growth and maintain prostate 
epithelium. In this study, green tea has a role in 
supressing the hemorrhage, reducing need of tranfusion, 
reducing VEGF expression and MVD count into the level 
that more significant with the combination of dutasteride 
and green tea. 
Combination of both dutasteride and green tea 
extract, given as anti angiogenic therapy in TURP 
procedure for BPH patient. Green tea inhibits the 
Pl3k/Akt pathway, reduce the VEGF production, and 
finally reduce the angiogenesis (Steel et al., 2000; Yang et 
al., 1998; Lill et al., 2003). Active component in green tea, 
EGCG; inhibits cell growth and endothelial cell growth. 
EGCG is a strong antioxidant and effectively inhibits the 
carsinogenic activity. EGCG inducing the phase-II 
detoxification enzymes, such as peroxidase, stop the cycle 
cell, induce apoptosis and prostate growth (Robb and 
Brown, 2001). EGCG also inhibits another growth factors 
in prostate, for example basic fibroblast growth factor 
(bFGF); epidermal growth factor (EGF), insulin-like 
growth factor (IGF).  Dutasteride reduces the growth 
factors by inhibiting the conversion testosterone into 
DHT, therefore  reducing the androgen activity (Mc 
Conenel et al., 1992; Ku et al., 2009). Both mechanism  
reduce the prostatic VEGF and MVD, minimize 
hemmorhage during TURP, reduce the haemoglobin 
r  = 0.303 r  = 0.451 
Figure 4. Scatter Graph VEGF correlation test 
against ΔHb, obtained value of r = 0.303 
showed a weak association between VEGF with 
Δ Hb 
Figure 5. Scatter Graph MVD against ΔHb 
correlation test, a score of r = 0.451 showed 
moderate correlation between MVD with Δ Hb 
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decrease during operation, and reducing tranfusion rate 
after TURP procedure. 
 
IV. CONCLUSIONS 
It can be concluded that administration of oral 
combination of  0.5 mg dutasteride and 725 mg extract 
green tea once daily, for at least 14 days prior to 
undergoing TURP, significantly reduce the hemorrhage 
during TURP procedure, by decreasing MVD 
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